These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 122764

  • 1. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM, Klara JW, Robertson J, Walker LC.
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [Abstract] [Full Text] [Related]

  • 2. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT, Clark MB, Hardin JC, Kostrzewa RM.
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [Abstract] [Full Text] [Related]

  • 3. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM, Garey RE.
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [Abstract] [Full Text] [Related]

  • 4. Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats.
    Klisans-Fuenmayor D, Harston CT, Kostrzewa RM.
    Brain Res Bull; 1986 Jan; 16(1):47-54. PubMed ID: 3082466
    [Abstract] [Full Text] [Related]

  • 5. Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa.
    Clark MB, King JC, Kostrzewa RM.
    Neurosci Lett; 1979 Aug; 13(3):331-6. PubMed ID: 530483
    [Abstract] [Full Text] [Related]

  • 6. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT, Clark MB, Hardin JC, Kostrzewa RM.
    Eur J Pharmacol; 1981 May 22; 71(4):365-73. PubMed ID: 6788574
    [Abstract] [Full Text] [Related]

  • 7. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM, Klisans-Fuenmayor D.
    Res Commun Chem Pathol Pharmacol; 1984 Oct 22; 46(1):3-11. PubMed ID: 6438742
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.
    Kostrzewa RM.
    Res Commun Chem Pathol Pharmacol; 1975 Aug 22; 11(4):567-79. PubMed ID: 1179028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH, Bhatnagar RK.
    Brain Res; 1979 Apr 27; 166(2):293-308. PubMed ID: 34468
    [Abstract] [Full Text] [Related]

  • 12. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH, Kasik SA, Bhatnagar RK.
    Brain Res; 1980 Jun 02; 191(1):173-90. PubMed ID: 7378749
    [Abstract] [Full Text] [Related]

  • 13. Partial damage to the noradrenergic bundle increases tyrosine hydroxylase activity in noradrenergic terminals of hippocampus but not cerebellum.
    Fluharty SJ, Stricker EM, Zigmond MJ.
    Brain Res; 1984 Dec 24; 324(2):390-3. PubMed ID: 6152190
    [Abstract] [Full Text] [Related]

  • 14. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa.
    Kostrzewa RM.
    Curr Top Behav Neurosci; 2016 Dec 24; 29():43-50. PubMed ID: 26660536
    [Abstract] [Full Text] [Related]

  • 15. Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa.
    Kostrzewa RM, Garey RE.
    Brain Res; 1977 Mar 25; 124(2):385-91. PubMed ID: 843956
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat.
    Blue ME, Molliver ME.
    Brain Res; 1987 Apr 25; 429(2):255-69. PubMed ID: 3105821
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G, Zieher LM.
    Eur J Pharmacol; 1977 Sep 15; 45(2):105-16. PubMed ID: 902684
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
    Harston CT, Morrow A, Kostrzewa RM.
    Brain Res Bull; 1980 Sep 15; 5(4):421-4. PubMed ID: 7407638
    [Abstract] [Full Text] [Related]

  • 20. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN, McLean JH, Kostrzewa RM.
    Pharmacol Biochem Behav; 1979 Sep 15; 11(3):309-12. PubMed ID: 504311
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.